Here, we observed that treatment of ALT-positive HGG and osteosarcoma cell lines with ROS-producing agents was a potent strategy for inducing hyper-ALT and could, therefore, represent an exciting new therapeutic approach in these difficult-to-treat cancers. This evidence concerns the gene GPT and osteosarcoma.